Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 840

Results For "MP"

9958 News Found

Kato wins USFDA approval for studies in retinal disorder
Biotech | February 17, 2022

Kato wins USFDA approval for studies in retinal disorder

Resolv ER may remedy leading causes of blindness in adults


Jubilant Ingrevia commissions Diketene derivatives facility
Biotech | February 17, 2022

Jubilant Ingrevia commissions Diketene derivatives facility

The commissioned facility has a capacity of 7,000 TPA to produce various Esters (Mono Methyl Acetoacetamide, Methyl Acetoacetate, Ethyl Acetoacetate, and Ter-Butyl Acetoacetate)


Rajiv Gupta to retire as chairman of Avantor
News | February 17, 2022

Rajiv Gupta to retire as chairman of Avantor

Gupta to retire at the end of his current term on May 12, 2022, after more than a decade of service, during which time Avantor has transformed into a global life sciences leader


Swissmedic  approves BeiGene's Brukinsa
Drug Approval | February 17, 2022

Swissmedic approves BeiGene's Brukinsa

With this approval, Brukinsa is now approved in 44 markets as BeiGene continues to advance its global registration, including the EU, US, and Great Britain


Pebble engages MD Anderson to evaluate multi-cannabinoid formulations in ovarian cancer
Biotech | February 17, 2022

Pebble engages MD Anderson to evaluate multi-cannabinoid formulations in ovarian cancer

Despite advances over the past 20 years, ovarian cancer treatment requires better standard of care


PerkinElmer’s SIRION Biotech and CRG to develop diabetes gene therapy
Biotech | February 17, 2022

PerkinElmer’s SIRION Biotech and CRG to develop diabetes gene therapy

Collaboration aims to evolve precision medicine with cell-specific delivery of gene therapy


USFDA approves Lupin’s Supplemental New Drug Application for Solosec
Drug Approval | February 17, 2022

USFDA approves Lupin’s Supplemental New Drug Application for Solosec

The supplemental adolescent approval enhances Solosec’s strong position as the first and only single-dose oral prescription antimicrobial agent approved for the treatment of both trichomoniasis and BV


Centauri Therapeutics closes £ 24 million Series A investment round
Startup | February 17, 2022

Centauri Therapeutics closes £ 24 million Series A investment round

Funding will support continued advancement of Centauri’s antimicrobial resistance research to identify novel therapeutic candidates using its proprietary Alphamer platform


Nirsevimab EMA regulatory submission accepted under accelerated assessment
Biotech | February 17, 2022

Nirsevimab EMA regulatory submission accepted under accelerated assessment

Nirsevimab is the first investigational long-acting antibody designed to protect all infants for the respiratory syncytial virus season with a single dose


Mankind Pharma acquires two brands from Dr Reddy’s
News | February 16, 2022

Mankind Pharma acquires two brands from Dr Reddy’s

The entire integration and transition of the brands is expected to be completed by March 2022